NETGEAR Schedules Third Quarter 2016 Results Conference Call
Oct 13, 2016 12:31 pm UTC| Business
SAN JOSE, Calif., Oct. 13, 2016 -- NETGEAR, Inc., (NASDAQ:NTGR), a global networking company that delivers innovative products to consumers, businesses and service providers, today announced that it will hold a...
Amyris Agrees to Collaboration Terms with Leading Global Food Ingredients and Nutraceuticals Partner
Oct 13, 2016 12:31 pm UTC| Business
EMERYVILLE, Calif., Oct. 13, 2016 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has executed a Memorandum of Understanding for a transformative strategic collaboration with a...
Stereotaxis Awarded Patent in China for Vdrive® System with V-Loop™ Manipulator
Oct 13, 2016 12:31 pm UTC| Business
ST. LOUIS, Oct. 13, 2016 -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that the State Intellectual Property Office of the...
Mitel Enables Seamless Smartphone and Business Phone Integration
Oct 13, 2016 12:31 pm UTC| Business
Automatic handoff from smartphone to desk phone and backShared access to contacts across both devicesWiFi connectivity untethers the desk phoneExecutive phone features high resolution 7” color touchscreenCharge mobile...
Oct 13, 2016 12:31 pm UTC| Business
Court dismissed lawsuit due to lack of FDA approval for LPCN-1021 and not on merits of case Clarus will be allowed to refile its lawsuit, if necessary NORTHBROOK, Ill., Oct. 13, 2016 -- Clarus Therapeutics, Inc....
Akorn Announces Third Quarter 2016 Earnings Release and Conference Call Information
Oct 13, 2016 12:31 pm UTC| Business
LAKE FOREST, Ill., Oct. 13, 2016 -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on Thursday, November 3, 2016 outlining the third...
Cellectar Biosciences To Present at BIO Investor Forum
Oct 13, 2016 12:30 pm UTC| Business
MADISON, Wis., Oct. 13, 2016 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces that Jarrod Longcor, senior vice president of...